Target intelligence / Profile preview

Neuronal plasticity (None (commonly referred to as "neuroplasticity" but not abbreviated as a standard target))

Target
None (commonly referred to as "neuroplasticity" but not abbreviated as a standard target)
Molecular classification
Other
01

Overview

Neuronal plasticity, more accurately termed **neuroplasticity**, is the capacity of the nervous system—particularly neural networks in the brain—to change structurally and functionally in response to intrinsic or extrinsic stimuli. This includes growth, reorganization, synaptic strengthening or weakening, neurogenesis (formation of new neurons), and functional reassignment of neural circuits. Neuroplastic changes are fundamental for learning new skills, memory formation, adaptation after sensory loss or injury (such as stroke), and overall cognitive development throughout life. While once thought limited to childhood development, neuroplastic processes persist into adulthood and underpin both healthy adaptation and recovery from neurological damage. However, **neuronal plasticity is not a single molecular entity** such as a receptor or enzyme; rather it describes a set of dynamic processes involving many different molecules and pathways within the nervous system. “Neuroplasticity...is the ability of neural networks in the brain to change through growth and reorganization.” Because neuronal/neuroplasticity refers broadly to these adaptive mechanisms rather than any specific molecule or druggable target class (like receptor/enzyme/transporter), it is **not considered a therapeutic target** itself but rather an emergent property resulting from multiple underlying molecular targets. **Note:** The entry "Neuronal plasticity" does not correspond to an individual molecule/receptor/target suitable for structured drug discovery data extraction; instead it represents a complex biological phenomenon involving many targets.

Other names
NeuroplasticityNeural plasticityBrain plasticityPlasticity (in neuroscience context)
02

Biological functions

Learning and memory formationRecovery from brain injury or strokeAdaptation to sensory or cognitive changesSynaptic remodeling and reorganization
03

Disease associations

Neurodegenerative disease (e.g., Alzheimer's, Parkinson's)Stroke recoveryTraumatic brain injury rehabilitationPsychiatric disorders (e.g., depression, schizophrenia)Other neurological conditions

Beyond the preview

Go deeper on Neuronal plasticity (None (commonly referred to as "neuroplasticity" but not abbreviated as a standard target)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal plasticity (None (commonly referred to as "neuroplasticity" but not abbreviated as a standard target)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call